UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by SeaCrest Wealth Management LLC


Share on StockTwits

SeaCrest Wealth Management LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,857 shares of the healthcare conglomerate’s stock after acquiring an additional 89 shares during the period. SeaCrest Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,703,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Carroll Financial Associates Inc. raised its holdings in UnitedHealth Group by 0.9% in the 4th quarter. Carroll Financial Associates Inc. now owns 3,200 shares of the healthcare conglomerate’s stock valued at $1,122,000 after acquiring an additional 30 shares during the last quarter. Harfst & Associates Inc. grew its stake in shares of UnitedHealth Group by 1.2% in the 4th quarter. Harfst & Associates Inc. now owns 2,565 shares of the healthcare conglomerate’s stock valued at $899,000 after buying an additional 31 shares during the period. Harvest Group Wealth Management LLC grew its stake in shares of UnitedHealth Group by 13.3% in the 4th quarter. Harvest Group Wealth Management LLC now owns 264 shares of the healthcare conglomerate’s stock valued at $93,000 after buying an additional 31 shares during the period. Pointe Capital Management LLC grew its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Pointe Capital Management LLC now owns 1,987 shares of the healthcare conglomerate’s stock valued at $619,000 after buying an additional 32 shares during the period. Finally, Hotaling Investment Management LLC grew its stake in shares of UnitedHealth Group by 0.3% in the 4th quarter. Hotaling Investment Management LLC now owns 12,876 shares of the healthcare conglomerate’s stock valued at $4,515,000 after buying an additional 33 shares during the period. Institutional investors own 86.03% of the company’s stock.

Several analysts have recently weighed in on the stock. Barclays reissued a “buy” rating and issued a $405.00 price target on shares of UnitedHealth Group in a research note on Sunday, January 17th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $360.00 to $430.00 in a research note on Wednesday, December 2nd. Mizuho increased their price target on shares of UnitedHealth Group from $361.00 to $380.00 and gave the company a “buy” rating in a research note on Monday, November 9th. Bank of America reaffirmed a “buy” rating and set a $415.00 price objective on shares of UnitedHealth Group in a research report on Thursday, January 21st. Finally, Credit Suisse Group increased their price objective on shares of UnitedHealth Group from $355.00 to $395.00 and gave the stock an “average” rating in a research report on Thursday, November 5th. Five investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $387.82.

In other news, CAO Thomas E. Roos sold 619 shares of UnitedHealth Group stock in a transaction dated Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total value of $200,494.10. Following the sale, the chief accounting officer now owns 31,908 shares of the company’s stock, valued at $10,335,001.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 7,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, December 8th. The shares were sold at an average price of $349.78, for a total transaction of $2,448,460.00. Following the completion of the sale, the director now directly owns 159,487 shares in the company, valued at approximately $55,785,362.86. The disclosure for this sale can be found here. Insiders have sold a total of 37,293 shares of company stock worth $12,886,401 over the last three months. 0.80% of the stock is currently owned by insiders.

NYSE:UNH traded up $2.19 during midday trading on Tuesday, hitting $329.83. 66,837 shares of the company were exchanged, compared to its average volume of 3,453,442. The company has a fifty day simple moving average of $341.25 and a 200 day simple moving average of $330.10. UnitedHealth Group Incorporated has a fifty-two week low of $187.72 and a fifty-two week high of $367.95. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $312.95 billion, a PE ratio of 18.82, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 19th. The healthcare conglomerate reported $2.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.39 by $0.13. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The firm had revenue of $65.47 billion for the quarter, compared to analyst estimates of $64.98 billion. During the same period last year, the business earned $3.90 EPS. UnitedHealth Group’s revenue for the quarter was up 7.5% compared to the same quarter last year. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

See Also: Analyst Ratings

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.